{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:10:10Z","timestamp":1778202610375,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.urolonc.2026.111080","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:08:16Z","timestamp":1774768096000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is complete TURBT mandatory before radical cystectomy in cases of muscle-invasive bladder cancer?"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-0332","authenticated-orcid":false,"given":"Keval N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poojitha","family":"Yalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashank J.","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2026.111080_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111080_bib0002","doi-asserted-by":"crossref","first-page":"76.e15","DOI":"10.1016\/j.urolonc.2020.07.011","article-title":"\"Real-world\" outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma","volume":"39","author":"Drakaki","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111080_bib0003","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.21037\/tau.2020.03.23","article-title":"Radical cystectomy: a review of techniques, developments and controversies","volume":"9","author":"Aminoltejari","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111080_bib0004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111080_bib0005","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.21037\/tau.2019.09.38","article-title":"Transurethral resection of bladder tumour (TURBT)","volume":"9","author":"Kim","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111080_bib0006","doi-asserted-by":"crossref","first-page":"34.e17","DOI":"10.1016\/j.urolonc.2016.08.005","article-title":"Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: is therapeutic effect owing to chemotherapy or TURBT?","volume":"35","author":"Brant","year":"2017","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111080_bib0007","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2011.11.010","article-title":"Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience","volume":"61","author":"Efstathiou","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111080_bib0008","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/JU.0000000000003193","article-title":"Impact of maximal transurethral resection on pathological outcomes at cystectomy in a large, multi-institutional cohort","volume":"209","author":"Kirk","year":"2023","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111080_bib0009","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.urolonc.2026.111080_bib0010","doi-asserted-by":"crossref","first-page":"787.e9","DOI":"10.1016\/j.urolonc.2021.03.025","article-title":"Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"39","author":"Pak","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111080_bib0011","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2026.111080_bib0012","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.urolonc.2021.01.013","article-title":"Surgical challenges and considerations in tri-modal therapy for muscle invasive bladder cancer","volume":"40","author":"Feldman","year":"2022","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111080_bib0013","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clgc.2014.01.005","article-title":"Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer","volume":"12","author":"James","year":"2014","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111080_bib0014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CU9.0000000000000110","article-title":"Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: a case-control study","volume":"16","author":"Yuan","year":"2022","journal-title":"Curr Urol"},{"key":"10.1016\/j.urolonc.2026.111080_bib0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.21037\/atm-20-2108","article-title":"An overview of patients with urothelial bladder cancer over the past two decades: a surveillance, Epidemiology, and End results (SEER) study","volume":"8","author":"Zang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111080_bib0016","doi-asserted-by":"crossref","first-page":"736.e11","DOI":"10.1016\/j.urolonc.2020.05.032","article-title":"Does grossly complete transurethral resection improve response to neoadjuvant chemotherapy?","volume":"38","author":"Ghandour","year":"2020","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111080_bib0017","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1590\/s1677-5538.ibju.2023.0123","article-title":"Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer","volume":"49","author":"Baird","year":"2023","journal-title":"Int Braz J Urol"},{"issue":"34","key":"10.1016\/j.urolonc.2026.111080_bib0018","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","article-title":"Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233","volume":"32","author":"Mak","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111080_bib0019","doi-asserted-by":"crossref","first-page":"300.e7","DOI":"10.1016\/j.urolonc.2020.11.034","article-title":"The natural history of muscle-invasive bladder cancer in geriatric patients undergoing transurethral resection only: outcome and cost","volume":"39","author":"Degener","year":"2021","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2026.111080_bib0020","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00345-021-03675-9","article-title":"En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting","volume":"39","author":"Teoh","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.111080_bib0021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/BLC-200273","article-title":"In the world of bladder tumors: size does matter","volume":"6","author":"Loloi","year":"2020","journal-title":"Bladder Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2026.111080_bib0022","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.juro.2010.04.008","article-title":"Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer","volume":"184","author":"Solsona","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111080_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2001.19.1.89","article-title":"Transurethral resection of muscle-invasive bladder cancer: 10-year outcome","volume":"19","author":"Herr","year":"2001","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2026.111080_bib0024","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00345-019-02734-6","article-title":"The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy","volume":"37","author":"Zamboni","year":"2019","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:29:17Z","timestamp":1778200157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078143926000918"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111080","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is complete TURBT mandatory before radical cystectomy in cases of muscle-invasive bladder cancer?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}